The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5'-O-[N-(D-alanyl)-sulfamoyl]adenosine ID: ALA5283680
Max Phase: Preclinical
Molecular Formula: C14H21N7O7S
Molecular Weight: 431.43
Associated Items:
Names and Identifiers Canonical SMILES: C[C@@H](N)C(=O)NS(=O)(=O)OC[C@H]1O[C@@H](Cn2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O
Standard InChI: InChI=1S/C14H21N7O7S/c1-6(15)14(24)20-29(25,26)27-3-8-11(23)10(22)7(28-8)2-21-5-19-9-12(16)17-4-18-13(9)21/h4-8,10-11,22-23H,2-3,15H2,1H3,(H,20,24)(H2,16,17,18)/t6-,7+,8-,10+,11-/m1/s1
Standard InChI Key: JEDANUNJCYBTAT-MWRVJPDDSA-N
Molfile:
RDKit 2D
29 31 0 0 0 0 0 0 0 0999 V2000
-1.2331 -0.9125 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.5657 -0.4275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1878 -0.7631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9023 -0.3506 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.5154 -0.9026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3224 -0.7312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5773 0.0533 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.0924 0.7208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5773 1.3882 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.3619 1.1333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3619 0.3083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0764 -0.1041 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.7908 0.3083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7908 1.1333 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.0764 1.5458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0764 2.3708 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.1798 -1.6563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3593 -1.5701 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1926 -2.1832 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.5923 -2.3708 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.9871 -0.5769 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-2.6546 -1.0620 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.4086 -0.7264 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0762 -1.2115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4086 0.0988 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.5737 0.1390 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.3989 0.1390 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.7908 -0.7989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0762 -2.0367 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 1
4 3 1 0
4 5 1 0
5 6 1 1
6 7 1 0
8 7 1 0
8 9 2 0
9 10 1 0
11 7 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
10 15 1 0
14 15 2 0
15 16 1 0
5 17 1 0
3 18 1 0
17 18 1 0
18 19 1 6
17 20 1 6
1 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
23 25 2 0
21 26 2 0
21 27 2 0
24 28 1 6
24 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 431.43Molecular Weight (Monoisotopic): 431.1223AlogP: -3.38#Rotatable Bonds: 7Polar Surface Area: 217.80Molecular Species: ACIDHBA: 13HBD: 5#RO5 Violations: 1HBA (Lipinski): 14HBD (Lipinski): 7#RO5 Violations (Lipinski): 2CX Acidic pKa: 2.75CX Basic pKa: 6.75CX LogP: -4.15CX LogD: -4.17Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.29Np Likeness Score: 0.20
References 1. Serpi M, Ferrari V, Pertusati F.. (2016) Nucleoside Derived Antibiotics to Fight Microbial Drug Resistance: New Utilities for an Established Class of Drugs?, 59 (23): [PMID:27607900 ] [10.1021/acs.jmedchem.6b00325 ]